No products in the cart.
C-peptide/AHSG: Target/Biomarker Introduction, products summarized (antibody/ADC/bispecific/antigen/ORF vector/VLP) and disease/indication/condition/MOA for drug discovery and IVD
It’s the GeneMedi’s summary page for Target/Biomarker Introduction of C-peptide/AHSG. The page also collects GeneMedi’s different modalities and formats products for C-peptide in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi’s target-insight database-GM ITD database, the C-peptide target is also connected to human indications/diseases/conditions/MOA.
Target sublocation: Secreted Protein/Potential Cytokines.
The protein encoded by this gene is a negatively-charged serum glycoprotein that is synthesized by hepatocytes. The encoded protein consists of two polypeptide chains, which are both cleaved from a proprotein encoded from a single mRNA. It is involved in several processes, including endocytosis, brain development, and the formation of bone tissue. Defects in this gene are a cause of susceptibility to leanness. [provided by RefSeq, Aug 2017]
|
Target ID |
GM-T97036
|
|
Target Name |
C-peptide
|
|
Gene ID |
197
|
|
Gene Official Name |
AHSG
|
|
Gene Alias |
A2HS, AHS, APMR1, FETUA, HSGA
|
|
Protein Sub-location |
Secreted Protein/Potential Cytokines
|
|
Category |
Therapeutics Target, Diagnostics Biomarker
|
Anti-FETUA/ C-peptide/ AHSG functional antibody for cell culture, ELISA & in-vivo assay| GMab
Pre-made anti-C-peptide benchmark inhibitory monoclonal antibody(mab, blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-C-peptide mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Filters
Sort results
Reset
Apply
Cat No. | Antibody Name | Format | Classified by tag | Order
|
|---|---|---|---|---|
Anti-C-peptide/AHSG monoclonal antibody |
mab |
FACS/Biofunctional Antibody, Therapeutics Target antibody, Diagnostic target antibody |
